Phloroglucinol, Trimethylphloroglucinol

Description

Empowering Gastrointestinal Comfort: PharmAlliance International Labs’ Phloroglucinol, Trimethylphloroglucinol Range

Welcome to PharmAlliance International Labs, where we are committed to revolutionizing patient care through innovative pharmaceutical solutions. Our Phloroglucinol, Trimethylphloroglucinol Range represents a breakthrough in gastrointestinal therapy, offering effective relief for a variety of conditions to enhance patient well-being and comfort.

Understanding the Drug Class:

Phloroglucinol, Trimethylphloroglucinol belongs to the class of medications known as antispasmodics. These agents work by targeting the smooth muscles of the gastrointestinal tract, where they exert their therapeutic effects by relaxing muscle spasms and alleviating associated symptoms. By restoring gastrointestinal harmony, Phloroglucinol, Trimethylphloroglucinol helps individuals manage their conditions and reclaim control over their health.

Comprehensive Formulations:

Our Phloroglucinol, Trimethylphloroglucinol Tablets offer a precise combination of 80mg of Phloroglucinol and 80mg of Trimethylphloroglucinol in each tablet, providing convenient oral administration for patients. Packed in containers containing 30 tablets, our formulations prioritize ease of use and adherence to treatment protocols, ensuring consistent symptom relief and improved quality of life.

Indications and Utilization:

Phloroglucinol, Trimethylphloroglucinol is indicated for the treatment of various gastrointestinal conditions, including abdominal pain associated with irritable bowel syndrome (IBS), functional gastrointestinal disorders, spastic colitis, as well as acute and chronic spasmodic pain such as biliary colic and renal colic. Administered orally with water before meals, our tablets offer flexible dosing options tailored to individual patient needs.

Optimized Dosage and Pharmacokinetics:

The recommended dosage of Phloroglucinol, Trimethylphloroglucinol may vary based on the severity of symptoms and individual patient response. Typically, adults may take one tablet up to three times daily as needed for symptom relief, with a maximum daily dose not exceeding three tablets. Rapidly absorbed from the gastrointestinal tract, Phloroglucinol, Trimethylphloroglucinol achieves peak plasma concentrations within 1 to 2 hours, providing swift relief when needed most.

Enhancing Patient Comfort:

Phloroglucinol, Trimethylphloroglucinol acts locally on the smooth muscles of the gastrointestinal tract, inhibiting muscle contractions and reducing spasms to alleviate discomfort. While generally well-tolerated, mild side effects such as gastrointestinal upset, headache, or dizziness may occur. However, serious adverse reactions are rare, underscoring the safety and efficacy of our formulations.

Conclusion:

In conclusion, PharmAlliance International Labs is proud to introduce our Phloroglucinol, Trimethylphloroglucinol Range—a testament to our unwavering commitment to advancing gastrointestinal therapy and improving patient outcomes. With a focus on innovation, quality, and patient-centered care, we invite you to experience the transformative relief offered by our formulations. Together, let us embark on a journey towards enhanced gastrointestinal comfort and vitality for individuals worldwide.